News

Info

Feb. 17, 2025

Stockmark, one of our portfolio companies, has been selected as one of Forbes Japan's "Japan's AI 50," an article inspired by "AI 50" by Forbes US.

Info

Jan. 23, 2025

Cyfuse, a former portfolio company, has been interviewed by the Tokyo Metropolitan Government's Bureau of Industrial and Labor Affairs, alongside our team.

Info

Dec. 26, 2024

Tomoko Masuda from our team was invited as a speaker at the Tokyo Metropolitan Government’s 2nd Fundraising Seminar for Female Entrepreneurs, where she gave a lecture on fundraising strategies.

Info

Nov. 18, 2024

DCI Partners: Satoshi Motomura, Head of Taipei Representative Office, contributes to Nikkei Biotechnology & Business: "Action-driven and speed-focused: what we can learn from Taiwanese management."

Info

Oct. 22, 2024

Notice: Unauthorized messages claiming to represent Daiwa Corporate Investment and impersonating its officers/employees.

IPO

Jul. 2, 2024

DCI Partners: PRISM BioLab Co.,Ltd. is listed on Tokyo Stock Exchange.

• Listed on Jul. 2, 2024

• TSE Growth: 206A

Info

Jun. 10, 2024

DCI Partners: Satoshi Motomura, Head of Taipei Representative Office, contributes to Nikkei Biotechnology & Business: "Why do Taiwanese startups have such high market caps?"

Info

May 16, 2024

Announcement of the establishment of "Daiwa EMP Private Fund1 L.P."

Info

Jan. 15, 2024

Notice: A message impersonating an officer/employee of Daiwa Corporate Investment.

Info

Nov. 27, 2023

DCI Partners: Yuka Niimi, from DCI Partners, has been ranked 5th in the "Japan's Venture Capitalist of the Year" by Forbes JAPAN (a Japanese edition of "The Midas List" by Forbes).

Info

Nov. 3, 2023

Jun Okuda, our head of the Ho Chi Minh Representative Office, has participated in "Inno Vietnam - Japan Fast Track Pitch 2023", an event held in Hanoi, Vietnam, co-organized by the Ministry of Economy, Trade and Industry of Japan, JETRO, the Ministry of Planning and Investment of Vietnam, and the Vietnam National Innovation Center.

IPO

Oct. 17, 2023

DCI Partners: K Pharma is listed on Tokyo Stock Exchange.

• Listed on Oct. 17, 2023

• TSE Growth: 4896

IPO

Jun. 28, 2023

DCI Partners: Noile-Immune Biotech is listed on Tokyo Stock Exchange.

• Listed on Jun. 28, 2023

• TSE Growth: 4893

Info

Jan. 19, 2023

DCI Partners: APRINOIA Therapeutics Inc. has entered into a definitive agreement for a business combination with Ross Acquisition Corp II, a SPAC founded by Mr. Wilbur Ross who is a prominent investor and the former Commerce Secretary of the United States.

Info

Sep. 22, 2022

Notice: A message impersonating an officer/employee of Daiwa Corporate Investment.

IPO

Sep. 24, 2021

DCI Partners: Renascience is listed on Tokyo Stock Exchange.

• Listed on Sep. 24, 2021

• TSE Mothers: 4889

Info

Nov. 4, 2020

Establishment of "DAIWA-SSIAM Vietnam Growth Fund III L.P."

Info

Jul. 12, 2019

Establishment of "DAIWA Myanmar Growth Fund".

IPO

Jun. 1, 2017

DCI Partners: ASLAN Pharmaceuticals Limited is listed on Taipei Exchange.

• Listed on Jun. 1, 2017

• TPEx: 6497

Info

Oct. 31, 2016

Establishment of "DAIWA-SSIAM Vietnam Growth Fund II L.P."

Info

Feb. 12, 2015

DCI Partners: Establishment of "Daiwa Taiwan-Japan Biotech Fund Investment Limited Partnership".

Info

Oct. 21, 2014

Daiwa Corporate Investment Co., Ltd. hereby announces the commencement of operation of its Taipei Representative Office.

Info

Aug. 5, 2011

Notice regarding Entry into with Nichii Gakkan Company of Tender Agreement with respect to Shares of GABA Corporation and Share Purchase Agreement with respect to Preferred Shares of GABA Corporation.

Info

May 19, 2010

Dissolution of Venture Capital Joint Venture.

Info

Nov. 25, 2009

New Business Collaboration with Saigon Securities Inc.

Info

Sep. 18, 2009

Establishment of the "RMB denominated Investment Fund" (Excerpt).